Live Breaking News & Updates on Kishor bhatia

Stay updated with breaking news from Kishor bhatia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lantern Pharma Inc. (LTRN) CEO Panna Sharma on Q1 2022 Results - Earnings Call Transcript

Lantern Pharma Inc. (NASDAQ:NASDAQ:LTRN) Q1 2022 Earnings Conference Call May 3, 2022 16:30 ET Company Participants Nicole Leber - Investor Relations Associate, Finance & Administrative...

University-of-texas , Texas , United-states , Australia , San-antonio , Australian , Keith-thompson , Michael-samuels , Maria-maccecchini , Kishor-bhatia , Peter-houghton , Nicole-leber

FDA Separately Grants Lantern Pharma and Codexis Rare Pediatric Disease Designations

FDA Separately Grants Lantern Pharma and Codexis Rare Pediatric Disease Designations
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

United-states , Kishor-bhatia , John-nicols , Mirum-pharmaceuticals , National-cancer-institute , Drug-administration , Rare-pediatric-disease , Orphan-drug , Lantern-pharma , Atypical-teratoid-rhabdoid-tumor , Receiving-rare-pediatric-disease-designation , New-drug-application

Lantern Pharma and NCI expand oncology partnership

Lantern Pharma the US National Institutes of Health unit NCI's DTB have extensed oncology collaboration for clinical trials for LP-184 and LP-284.

Kishor-bhatia , Broad-institute-project-achilles , Broad-institute , Project-achilles , Lantern-pharma , Deep-lens ,

Lantern Pharma Expands Precision Oncology Collaboration with the National Cancer Institute - Accelerating Path to First in Human Clinical Trials for Drug Candidates LP-184 & LP-284

/PRNewswire/ -- Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform...

Dallas , Texas , United-states , Kishor-bhatia , Broad-institute , National-cancer-institute , Exchange-commission-on , Twitter , National-institutes-of-health , Drug-administration , Society-of-neuro , Developmental-therapeutics-branch

Preclinical Data on New Pancreatic Cancer Drug Shines with over 90% Efficacy

Preclinical Data on New Pancreatic Cancer Drug Shines with over 90% Efficacy
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.

United-states , America , Kishor-bhatia , Igor-astsaturov , Marvin-conchetta-greenberg-pancreatic-cancer-institute , Fox-chase-cancer-center , Lantern-pharma , Conchetta-greenberg-pancreatic-cancer , ஒன்றுபட்டது-மாநிலங்களில் , அமெரிக்கா , கிஷோர்-பாட்டியா , நரி-துரத்து-புற்றுநோய்-மையம்

દ્વારકાના કિશોરભાઈ ભાટીયાનું કોરોનાથી મૃત્યુ

દ્વારકાના કિશોરભાઈ ભાટીયાનું કોરોનાથી મૃત્યુ
nobat.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nobat.com Daily Mail and Mail on Sunday newspapers.

Dubai , Dubayy , United-arab-emirates , Mumbai , Maharashtra , India , Jamnagar , Gujarat , Dwarkae-mohan-bhatia , Kishor-bhatia , Suresh-upadhyay ,

Lantern Pharma Announces Collaboration with World Leading Brain Cancer Program at Johns Hopkins to Further Develop LP-184 as Therapy for Glioblastoma

Share this article
Share this article
DALLAS, Dec. 17, 2020 /PRNewswire/ -- Lantern Pharma (Nasdaq: LTRN), a clinical-stage biopharma company using its proprietary RADR
® artificial intelligence ("A.I.") platform to transform cancer drug development and identify patients who will benefit from its targeted oncology therapeutics, today announced a collaboration and research agreement with the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Kennedy Krieger Institute. The collaboration will focus on the further development of Lantern's LP-184 in glioblastoma multiforme (GBM). Based in Baltimore, Johns Hopkins is a leading research center for brain cancers and one of the largest brain tumor treatment and research centers in the world with a focus on treating an extremely large number of patients affected by all types of brain tumors.

United-states , Dallas , Texas , Marek-ciszewski , John-laterra , Kishor-bhatia , Johns-hopkins , Division-of-neuro , National-cancer-institute , Brain-cancer-program , Twitter , Drug-administration